S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NYSE:BMY

Bristol-Myers Squibb News Headlines

$76.19
+0.23 (+0.30%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$75.34
$77.15
50-Day Range
$69.66
$78.22
52-Week Range
$53.22
$78.46
Volume
17.33 million shs
Average Volume
16.03 million shs
Market Capitalization
$162.21 billion
P/E Ratio
27.02
Dividend Yield
2.84%
Beta
0.49
Get Bristol-Myers Squibb News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Bristol-Myers Squibb Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BMY
News Sentiment

-0.02

0.30

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BMY Articles
This Week

23

14

BMY Articles
Average Week



Bristol-Myers Squibb (NYSE:BMY) News Headlines Today

SourceHeadline
marketbeat.com logoWells Fargo & Company Raises Bristol-Myers Squibb (NYSE:BMY) Price Target to $70.00
marketbeat.com - May 17 at 7:49 AM
marketbeat.com logoBristol-Myers Squibb (NYSE:BMY) Sees Large Decline in Short Interest
marketbeat.com - May 17 at 6:42 AM
seekingalpha.com logoBristol-Myers Squibb: A Safe Haven In Times Of Uncertainty
seekingalpha.com - May 20 at 10:11 PM
seekingalpha.com logoBristol-Myers Squibb's azacitidine granted additional indication for juvenile leukemia
seekingalpha.com - May 20 at 6:42 PM
finance.yahoo.com logoThe Evolution of Lung Cancer Research
finance.yahoo.com - May 19 at 5:14 PM
finance.yahoo.com logoBristol Myers Squibb Data at ASCO and EHA 2022 Highlight Progress in Transforming Treatment for Patients with Cancer and Blood Disorders
finance.yahoo.com - May 19 at 7:43 AM
seekingalpha.com logoImmatics begins dosing of IMA203 with Bristol Myers' Opdivo in trial to treat solid tumors
seekingalpha.com - May 18 at 8:54 AM
MarketBeat logoBristol-Myers Squibb (NYSE:BMY) Hits New 1-Year High After Analyst Upgrade
americanbankingnews.com - May 18 at 1:42 AM
finance.yahoo.com logoBristol Myers (BMY) Phase III CheckMate -901 Study Disappoints
finance.yahoo.com - May 17 at 3:31 PM
finance.yahoo.com logoBerkshire Hathaway exited Bristol Myers and AbbVie stakes in Q1
finance.yahoo.com - May 16 at 10:34 PM
seekingalpha.com logoBristol Myers' Opdivo/Yervoy combo fails to improve overall survival in certain bladder cancer patients in trial
seekingalpha.com - May 16 at 5:34 PM
finance.yahoo.com logoBristol Myers' Opdivo+Yervoy Fails To Meet Survival Endpoint In Untreated Urothelial Cancer
finance.yahoo.com - May 16 at 5:34 PM
finance.yahoo.com logoThe Quest To Stop Cancer From Coming Back
finance.yahoo.com - May 16 at 5:34 PM
nasdaq.com logoBristol Myers Squibb: Phase 3 CheckMate -901 Trial Fails To Meet Primary Endpoint
nasdaq.com - May 16 at 8:53 AM
finance.yahoo.com logoBristol Myers Squibb Provides Update on CheckMate -901 Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) as First-Line Treatment for Patients with Unresectable or Metastatic Urothelial Carcinoma
finance.yahoo.com - May 16 at 7:32 AM
finance.yahoo.com logoBridgeBio (BBIO) Up on Deal With BMY for SHP2 Inhibitor
finance.yahoo.com - May 13 at 3:55 PM
nasdaq.com logoBristol Myers To Sell East Syracuse Manufacturing Facility To Korea's LOTTE; Terms Not Disclosed
nasdaq.com - May 13 at 3:09 PM
seekingalpha.com logoBristol Myers to sell East Syracuse, New York production facility
seekingalpha.com - May 13 at 3:09 PM
finance.yahoo.com logoLOTTE to Purchase Bristol Myers Squibb Manufacturing Facility in East Syracuse, New York
finance.yahoo.com - May 13 at 3:09 PM
finance.yahoo.com logoCan Bristol-Myers Squibb Company (NYSE:BMY) Maintain Its Strong Returns?
finance.yahoo.com - May 12 at 3:43 PM
finance.yahoo.com logoBridgeBio Inks Licensing Pact With Bristol Myers For SHP2 Inhibitor In Oncology
finance.yahoo.com - May 12 at 1:32 PM
seekingalpha.com logoBristol Myers' deucravacitinib maintains efficacy at 2 years against plaque psoriasis in study
seekingalpha.com - May 12 at 8:32 AM
seekingalpha.com logoBristol Myers and BridgeBio Pharma partner for cancer candidate
seekingalpha.com - May 12 at 8:32 AM
finance.yahoo.com logoNew Two-Year Deucravacitinib Data Reinforce Durable Efficacy and Consistent Safety Profile in Treatment of Moderate to Severe Plaque Psoriasis
finance.yahoo.com - May 12 at 8:32 AM
markets.businessinsider.com logoEvotec, Bristol Myers Extend Partnership In Protein Degradation
markets.businessinsider.com - May 10 at 2:35 PM
seekingalpha.com logoBristol Myers extends protein degradation deal with Evotec
seekingalpha.com - May 10 at 2:35 PM
benzinga.com logoPeering Into Bristol-Myers Squibb's Recent Short Interest
benzinga.com - May 6 at 3:15 PM
MarketBeat logoBristol-Myers Squibb Forecasted to Earn FY2022 Earnings of $7.57 Per Share (NYSE:BMY)
americanbankingnews.com - May 6 at 3:24 AM
finance.yahoo.com logoTeva's Q1 Results: Is the Stock About to Crash?
finance.yahoo.com - May 5 at 5:44 PM
finance.yahoo.com logoWhy Is Hypertrophic Cardiomyopathy, the Most Commonly Inherited Heart Disease, Often Undiagnosed?
finance.yahoo.com - May 5 at 12:41 PM
MarketBeat logoQ2 2022 EPS Estimates for Bristol-Myers Squibb (NYSE:BMY) Reduced by Analyst
americanbankingnews.com - May 5 at 1:30 AM
finance.yahoo.com logoBristol Myers Squibb to Participate in Bank of America Securities 2022 Healthcare Conference
finance.yahoo.com - May 4 at 9:44 AM
stocknews.com logo4 Incredibly Cheap Large-Cap Stocks to Buy Now
stocknews.com - May 3 at 2:31 PM
MarketBeat logoBristol-Myers Squibb (NYSE:BMY) Price Target Raised to $80.00 at Guggenheim
americanbankingnews.com - May 3 at 5:24 AM
MarketBeat logoBristol-Myers Squibb (NYSE:BMY) Price Target Increased to $92.00 by Analysts at BMO Capital Markets
americanbankingnews.com - May 3 at 4:52 AM
MarketBeat logoBristol-Myers Squibb (NYSE:BMY) Given New $81.00 Price Target at Truist Financial
americanbankingnews.com - May 3 at 4:52 AM
MarketBeat logoBristol-Myers Squibb (NYSE:BMY) Price Target Increased to $68.00 by Analysts at Barclays
americanbankingnews.com - May 3 at 4:52 AM
benzinga.com logoBristol-Myers Squibb's Return On Capital Employed Overview
benzinga.com - May 2 at 2:21 PM
markets.businessinsider.com logoWhat 4 Analyst Ratings Have To Say About Bristol-Myers Squibb
markets.businessinsider.com - May 2 at 10:22 AM
MarketBeat logoBristol-Myers Squibb (NYSE:BMY) Sees Strong Trading Volume After Better-Than-Expected Earnings
americanbankingnews.com - May 1 at 2:22 AM
nasdaq.com logoBristol-Myers Squibb Slashes FY22 EPS, Adj. EPS Outlook; Q1 Results Top Estimates
nasdaq.com - April 29 at 9:01 PM
seekingalpha.com logoBristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com - April 29 at 4:00 PM
finance.yahoo.com logoCore PCE Inflation at a 40-Year High in March
finance.yahoo.com - April 29 at 4:00 PM
finance.yahoo.com logoBristol-Myers (BMY) Q1 Earnings Beat Estimates, Guidance Down
finance.yahoo.com - April 29 at 4:00 PM
finance.yahoo.com logoBristol Myers Squibb (BMY) Q1 2022 Earnings Call Transcript
finance.yahoo.com - April 29 at 4:00 PM
seekingalpha.com logoBristol Myers stock dips despite Q1 beat, as FY22 EPS outlook trimmed, Revlimid to see decline
seekingalpha.com - April 29 at 11:02 AM
investing.com logoBristol-Myers Squibb Earnings, Revenue Beat in Q1
investing.com - April 29 at 11:00 AM
nasdaq.com logoBristol Myers Squibb Reports FDA Approval Of Camzyos - Quick Facts
nasdaq.com - April 29 at 11:00 AM
finance.yahoo.com logoAmazon, Robinhood Slump in Premarket; Apple, Exxon, Bristol Myers-Squibb Fall
finance.yahoo.com - April 29 at 11:00 AM
finance.yahoo.com logoBristol Myers Squibb Reports First Quarter Financial Results for 2022
finance.yahoo.com - April 29 at 11:00 AM
finance.yahoo.com logoBristol Myers 1st-quarter sales up on Eliquis, Opdivo
finance.yahoo.com - April 29 at 11:00 AM
finance.yahoo.com logoBristol Myer Squibb's stock falls after cutting adjusted EPS for 2022
finance.yahoo.com - April 29 at 11:00 AM
Get Bristol-Myers Squibb News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.